(Q39612892)

13 September 2017

1 reference

title

Measurement of the quality of life in congestive heart failure--influence of drug therapy (English)

1 reference

13 September 2017

0 references

1 reference

congestive heart failure

1 reference

C J Bulpitt

1

1 reference

13 September 2017

A E Fletcher

series ordinal

2

1 reference

13 September 2017

publication date

1 November 1988

1 reference

Cardiovascular Drugs and Therapy

13 September 2017

published in

1 reference

13 September 2017

volume

2 Suppl 1

1 reference

13 September 2017

page(s)

419-424

1 reference

The Natural History of Congestive Heart Failure: The Framingham Study

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Pitfalls in the serial assessment of cardiac functional status. How a reduction in "ordinary" activity may reduce the apparent degree of cardiac compromise and give a misleading impression of improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

A quantitative approach to perceived health status: a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Use of multivariate measures of disability in health surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Surgery as placebo. A quantitative study of bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Functional and social rehabilitation of heart transplant recipients under age thirty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Clinical efficacy of hydralazine in chronic heart failure: one-year double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Captopril in heart failure. A double blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

A symptom questionnaire for hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

The symptom patterns of treated diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00633423

21 January 2018

Identifiers

DOI

10.1007/BF00633423

1 reference

13 September 2017

1 reference